Nonhuman Primate Models of Hiv-Associated Pulmonary, Cardiovascular, and Hematological Disorders
The summary for the Nonhuman Primate Models of Hiv-Associated Pulmonary, Cardiovascular, and Hematological Disorders grant is detailed below.
This summary states who is eligible for the grant, how much grant money will be awarded, current and past deadlines, Catalog of Federal Domestic Assistance (CFDA) numbers, and a sampling of similar government grants.
Verify the accuracy of the data FederalGrants.com provides by visiting the webpage noted in the Link to Full Announcement section or by contacting the appropriate person listed as the Grant Announcement Contact.
If any section is incomplete, please visit the website for the National Institutes of Health, which is the U.S. government agency offering this grant.
Nonhuman Primate Models of Hiv-Associated Pulmonary, Cardiovascular, and Hematological Disorders: The National Heart, Lung, and Blood Institute (NHLBI) invites applications on the use of nonhuman primate models for the study of Human Immunodeficiency Virus (HIV)-associated pulmonary, cardiovascular, and hematologic disorders. These primate models (e.g., Simian Immunodeficiency Virus [SIV]- and Simian-Human Immunodeficiency Virus [SHIV]-infected monkeys) should be designed to facilitate the study of the biological and clinical characteristics of disorders of lung, heart, blood, and bone marrow, associated with HIV infections and co-infections as well as to evaluate novel methods for prevention and treatment of these conditions.
| Federal Grant Title: | Nonhuman Primate Models of Hiv-Associated Pulmonary, Cardiovascular, and Hematological Disorders |
| Federal Agency Name: | National Institutes of Health |
| Grant Categories: | Health |
| Type of Opportunity: | Discretionary |
| Funding Opportunity Number: | RFA-HL-03-005 |
| Type of Funding: | Grant |
| CFDA Numbers: | 93.838 |
| CFDA Descriptions: | Lung Diseases Research |
| Current Application Deadline: | No deadline provided |
| Original Application Deadline: | Mar 20, 2003 |
| Posted Date: | Dec 10, 2002 |
| Creation Date: | Apr 19, 2003 |
| Archive Date: | Apr 19, 2003 |
| Total Program Funding: | |
| Maximum Federal Grant Award: | |
| Minimum Federal Grant Award: | |
| Expected Number of Awards: | |
| Cost Sharing or Matching: | No |
- Applicants Eligible for this Grant
- State governments County governments City or township governments Special district governments Independent school districts Public and State controlled institutions of higher education Native American tribal governments (Federally recognized) Public housing authorities/Indian housing authorities Native American tribal organizations (other than Federally recognized tribal governments) Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education Private institutions of higher education For profit organizations other than small businesses Small businesses Others (see text field entitled "Additional Information on Eligibility" for clarification)
- Link to Full Grant Announcement
- Information not provided
- Grant Announcement Contact
- If you have any problems linking to this funding announcement, please contact the NIH OER Webmaster [email protected] NIH OER Webmaster
- Similar Government Grants
- • Viral INfections in the Young Lung- The VINYL Clinical Consortium- Data Analytics and Coor...
- • Viral INfections in the Young Lung- The VINYL Clinical Consortium (UG3/UH3 Clinical Trial ...
- • Limited Competition: Physician Scientist Transition to Independence in Blood Science Resea...
- • Single Source: Molecular Atlas of Lung Development Program (LungMAP) Phase 3 - Data Coordi...
- • Single Source: Molecular Atlas of Lung Development Program (LungMAP) Phase 3 - Human Tissu...
- • Pathogenesis of Sars Lung Disease: in Vitro Studies and Animal Models
- • Lung Response to Inhaled Highly Toxic Chemicals
- • Protein Interactions Governing Membrane Transport in Pulmonary Health and Disease (R01)
- More Grants from the National Institutes of Health
- • Translational Centers Using Microphysiological Systems for Infectious Diseases (U54 Clinic...
- • Immune Tolerance Network (UM1 Clinical Trial Required)
- • Coordinating Center for National Resource Network for the Study of Human Auditory and Vest...
- • National Resource Network for the Study of Human Auditory and Vestibular Disorders (U24 Cl...
- • Pilot and Feasibility Studies in Preparation for Substance Use and HIV Prevention Interven...
